SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 1st, 2016 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 1st, 2016 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 27, 2016, between RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 1st, 2016 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJuly 1st, 2016 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of June 27, 2016, between RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
ContractRegenerx Biopharmaceuticals Inc • July 1st, 2016 • Pharmaceutical preparations • New York
Company FiledJuly 1st, 2016 Industry JurisdictionNEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.